NYSE •
Healthcare •
Drug Manufacturers - General •
Quote as of 06/26/2026 15:34
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization292,167 mln
Float1,812 mln
Earnings Date07/21/2026
EPS
6.98
Strong
P / E
22.24
Premium valuation
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.7
Likely reliable
Relative Strength
65
/ 100
Outperforming
Debt / Equity
1.22
Elevated leverage
Business Description
Novartis AG is a Swiss-based global pharmaceutical company founded in 1996 and headquartered in Basel, with operations spanning multiple countries worldwide. The company researches, develops, and sells a broad range of medicines targeting serious health conditions, including heart disease, cancer, immune disorders, and neurological conditions. Its product portfolio includes well-known treatments such as Entresto for heart failure, Cosentyx for inflammatory diseases, Kisqali for certain cancers, and Zolgensma for spinal muscular atrophy, among many others.
